It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Liver cancer, a chronic non-communicable disease, represents a serious public health problem. Long-term trends in the burden of liver cancer disease are heterogeneous across regions. Incidence and mortality of liver cancer, based on the Global Burden of Disease, were collected from the Chinese Centre for Disease Control and Prevention. Age–period–cohort model was utilized to reveal the secular trends and estimate the age, period and cohort effects on primary liver cancer due to specific etiologies. Both the age-standardized incidence and mortality rate of liver cancer in Hubei province were on the rise, although there were discrepancies between gender groups. From age–period–cohort analysis, both incidence and mortality of liver cancer due to Hepatitis B virus were the highest in all age groups. The incidence of all liver cancer groups increased with time period in males, while this upward trend was observed in females only in liver cancer due to alcohol use group. Cohort effects indicated the disease burden of liver cancer decreased with birth cohorts. Local drifts showed that the incidence of liver cancer due to specific etiologies was increasing in the age group of males between 40 and 75 years old. The impact of an aging population will continue in Hubei Province. the disease burden of liver cancer will continue to increase, and personalized prevention policies must be adopted to address these changes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hubei Provincial Center for Disease Control and Prevention, Institute of Chronic Disease Prevention and Cure, Wuhan, China (GRID:grid.508373.a) (ISNI:0000 0004 6055 4363)
2 Hubei Provincial Center for Disease Control and Prevention, Institute of Health Inspection and Testing, Wuhan, China (GRID:grid.508373.a) (ISNI:0000 0004 6055 4363)
3 Wuhan University, Department of Occupational and Environmental Health, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)
4 Wuhan Changjiang New Area Center for Disease Control and Prevention, Wuhan, China (GRID:grid.49470.3e); Wuhan University, Department of Public Health, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)
5 Wuhan University, Department of Public Health, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)